MHRA: Advertising Investigations Decisions for August 2026

We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. You have accepted additional cookies. You can change your cookie settings at any time. You have rejected additional cookies. You can change your cookie settings at any time. Decisions made by MHRA on adverts reported to have breached the legislation on advertising medicines. Get emails about this page Documents Medicinal treatment services for weight loss – August 2026 HTML Promotion of a Prescription-Only Medicine to the public and promotion of a medicinal product prior to grant of a UK Marketing Authorisation by Innox Trading Ltd trading as Chemist4U – August 2026 HTML Websites offering medicinal treatment services for hay fever – August 2026 HTML Contact advertising@mhra.gov.uk if you have concerns with the advertising of medicines or write to: Advertising Standards Unit, 10 South Colonnade, Canary Wharf, London E14 4PU Alternatively, contact the pharmaceutical self-regulatory bodies, the Proprietary Association of Great Britain (PAGB) for advertising for over the counter medicines, or the Prescription Medicines Code of Practice Authority (PMCPA) for advertisements to health professionals for prescription medicines. See the Blue Guide for guidance on how medicines should be promoted or advertised in the UK. Get emails about this page Print this page Related content Is this page useful? Maybe Yes this page is useful No this page is not useful Thank you for your feedback Report a problem with this page Help us improve GOV.UK Do not include personal or financial information like your National Insurance number or credit card details. To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript ) .